Sichuan Kelun-Biotech Biopharmaceutical’s License Agreement with Merck

Goodwin Procter advised Sichuan Kelun-Biotech Biopharmaceutical Co. on the deal.Sichuan Kelun-Biotech Biopharmaceutical Co. announced its exclusive license and collaboration agreement with Merck for ex-China development rights…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now